Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Aptinyx
1801 Maple Avenue, Suite 4300
Evanston, IL 60201
Phone: 847-871-0377
http://www.aptinyx.com/

Aptinyx Inc. is a biopharmaceutical company focused on discovery and development of transformative therapies for challenging neurological disorders. Aptinyx has a proven platform for discovering compounds that enhance synaptic plasticity, or strengthen the network for neural cell communication. Molecules discovered by Aptinyx achieve this through a novel mechanism that modulates NMDA receptors, resulting in drugs that are both highly effective and well tolerated.

Key Contact
Name
Norbert G. Riedel, Ph.D.
Title
President and CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
05/10/16 $65,000,000 Series A Adams Street Partners
Beecken Petty O'Keefe & Company
Frazier Healthcare
Goudy Park Capital
Longitude Capital
LVP Life Sciences Ventures
New Leaf Venture Partners
Northwestern University
Osage University Partners
PathoCapital
12/18/17 $70,000,000 Series B Adage Capital Management
Adams Street Partners
Agent Capital
Bain Capital
Frazier Healthcare
HBM Healthcare Investments
Longitude Capital
LVP Life Sciences Ventures
Nan Fung
New Leaf Venture Partners
Partner Fund Management
Rock Springs Capital


Featured Reading